title: Are Rogerofenib and Nilotinib Effective for Advanced Gastrointestinal Stromal Tumor (GIST) Patients who have Already been Given Main Treatments?
authors.affiliation: Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey E-mail : dr-ozaslan@hotmail.com.
authors.forename: Ersin
authors.initials: E
authors.lastname: Ozaslan
authors.forename: Metin
authors.initials: M
authors.lastname: Ozkan
authors.forename: Oktay
authors.initials: O
authors.lastname: Bozkurt
authors.forename: Ayse Ocak
authors.initials: AO
authors.lastname: Duran
authors.forename: Mahmut
authors.initials: M
authors.lastname: Ucar
authors.forename: Baki
authors.initials: B
authors.lastname: Eker
authors.forename: Veli
authors.initials: V
authors.lastname: Berk
authors.forename: Halit
authors.initials: H
authors.lastname: Karaca
mesh_terms: D000328:Adult; D005260:Female; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D011505:Protein-Tyrosine Kinases; C498826:nilotinib